SCHEDULE 13G/A: Rosalind Advisors and Affiliates Disclose 9.9% Passive Stake in InspireMD, Inc. with Blocker Provisions

Rosalind Advisors, Inc. and its affiliated funds have filed an amended Schedule 13G, disclosing a collective passive beneficial ownership of 9.9% in InspireMD, Inc., including common shares and warrants, subject to a 9.99% ownership blocker.

Summary

• Rosalind Advisors, Inc., along with Rosalind Master Fund L.P., Rosalind Opportunities Fund I L.P., Steven Salamon, and Gil Aharon, collectively reported a beneficial ownership of 9,933,964 shares of InspireMD, Inc. common stock.
• This reported amount represents 9.9% of InspireMD's common stock, based on 26,083,763 shares outstanding as of November 8, 2024.
• The total beneficial ownership includes 2,495,783 shares of common stock directly held and 7,438,181 shares issuable upon the exercise of pre-funded and standard warrants.
• A significant 'blocker provision' is in place, preventing the holders from exercising any warrants if such exercise would result in beneficial ownership exceeding 9.99% of InspireMD's common stock.
• Due to these blocker provisions, the reporting persons were unable to exercise any of the warrants as of the event date (December 31, 2024).
• The 2,495,783 shares of common stock currently held by Rosalind Master Fund L.P. and Rosalind Opportunities Fund I L.P. represent approximately 9.57% of the outstanding common shares.
• The filing confirms that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of InspireMD, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a 13G is a routine disclosure, the presence of a significant institutional investor holding a passive stake can be viewed as a vote of confidence, even if the warrants are currently unexercisable due to blocker provisions.

Positives

• A significant passive stake by institutional investors like Rosalind Advisors and its funds can signal confidence in the company's long-term prospects.
• The investment is stated to be in the ordinary course of business, indicating a standard portfolio allocation rather than an activist intent.

Risks

• The 'blocker provision' on warrants limits the ability of Rosalind Advisors and its affiliates to increase their ownership beyond 9.99% through warrant exercise, potentially restricting their flexibility or influence if they wished to expand their stake further in the future.

Future Outlook

The document does not provide any forward-looking statements or guidance from InspireMD, Inc. or the reporting persons regarding the company's future performance or strategic direction.

Industry Context

This filing is a routine disclosure of a significant passive ownership stake by an institutional investor in a publicly traded company. It does not provide specific insights into broader industry trends or competitive landscape beyond the ownership structure of InspireMD, Inc.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake, which can influence investor perception and potentially liquidity.
• Company Management: Awareness of a large passive investor, though without direct control implications.

Key Dates

Keywords

InspireMD Inc., Rosalind Advisors, Schedule 13G, Beneficial Ownership, Common Shares, Warrants, Institutional Investor, Passive Investment, SEC Filing, Corporate Ownership